 |
| Product information |
Product name | Aniracetam |
CAS No. | 72432-10-1 |
Molecular Formula | C12H13NO3 |
Molecular Weight | 219.24 |
Quality Standard | 98% up by HPLC ,WC,DMF |
Appearance | White or off-white crystalline powder |
| COA Of Aniracetam |
ANALYSIS | SPECIFICATION | RESULTS |
Appearance | White or off - white crystalline powder, odorless and a little bitter | Conforms |
Melting Point | 118 - 122 °C | 120.1 - 121.9 °C |
Absorbance | 476 - 506 | 492 |
Chemical Reaction | Generate white precipitate | Conforms |
IR Identification | Should comply with the reference spectrum | Comply with the reference spectrum |
Related Substances - Individual Impurity | ≤0.2% | 0.1% |
Related Substances - Total Impurities | ≤0.5% | 0.2% |
Residual solvent - Methanol | ≤0.3% | ND |
Residual solvent - Ethanol | ≤0.5% | ND |
Residual solvent - Ethyl Acetate | ≤0.5% | ND |
Residual solvent - Toluene | ≤0.089% | ND |
Loss on Drying | ≤0.5% | 0.40% |
Residual on Ignition | ≤1.0% | 0.05% |
Heavy metals | ≤10ppm | Conforms |
Assay | 98.0% - 102.0% | 101.0% |
Microbial Limit - Bacterial count | ≤1000cfu/g | <10cfu/g |
Microbial Limit - Mold and Yeast Count | ≤100cfu/g | <10cfu/g |
Microbial Limit - Escherichia Coli | Not detected | Not detected |
Conclusion | The sample conforms to the Specifications. |
Aniracetam – High-Purity Nootropic API Manufactured for Cognitive Health Innovations |
Aniracetam (CAS 72432‑10‑1) is a fat-soluble cognitive enhancer from the racetam family, widely recognized for its potential in supporting memory, attention, and neuroprotection. As a leading manufacturer and global supplier of Aniracetam powder, we offer GMP-compliant active pharmaceutical ingredients (APIs) engineered for advanced neurological applications, including Aniracetam supplements, research-grade nootropics, and cognitive disorder formulations.
Controlled Synthesis for Clinical-Grade Purity |
Our production of Aniracetam nootropic API is based on a robust chemical synthesis pathway starting from 2-pyrrolidone derivatives, conducted in strictly monitored reactor systems to ensure high yield and product consistency.
Raw Material Quality Control
Each batch begins with pharmaceutical-grade intermediates. In-process QC checks ensure structural integrity essential for Aniracetam AMPA receptor potentiator activity.
Precision Reaction and Crystallization
Our proprietary synthesis method supports optimal bioactivity, helping maximize Aniracetam for memory and attention disorders efficacy. Crystallization and solvent removal steps are conducted under vacuum to avoid degradation of the active molecule.
High-Purity Filtration & Drying
Final purification includes multiple solvent washes, followed by low-temperature vacuum drying. The result is a stable, fine Aniracetam powder ideal for capsule or tablet formulation.
Analytical Validation
Every lot undergoes HPLC, NMR, and MS testing to ensure compliance with global standards, including low residual solvents and heavy metals—supporting applications in Aniracetam for ADHD cognitive improvement and Aniracetam therapeutic potential in dementia and Alzheimer’s.
Scientific Backing & Application Potential |
Emerging research supports Aniracetam BDNF and amyloid‑β modulation, making it a candidate for age-related neurodegenerative diseases. Animal studies confirm Aniracetam anxiolytic effects in rodents, while new trials exploring Aniracetam safety and clinical evidence 2024 continue to build confidence in its nootropic and neuroprotective benefits.
We also support formulators targeting niche neurological markets. Whether your focus is Aniracetam for memory and attention disorders, AMPA modulation, or Aniracetam supplement innovation, our technical and regulatory teams provide comprehensive documentation and support.
| Product information |
Product name | Aniracetam |
CAS No. | 72432-10-1 |
Molecular Formula | C12H13NO3 |
Molecular Weight | 219.24 |
Quality Standard | 98% up by HPLC ,WC,DMF |
Appearance | White or off-white crystalline powder |
| COA Of Aniracetam |
ANALYSIS | SPECIFICATION | RESULTS |
Appearance | White or off - white crystalline powder, odorless and a little bitter | Conforms |
Melting Point | 118 - 122 °C | 120.1 - 121.9 °C |
Absorbance | 476 - 506 | 492 |
Chemical Reaction | Generate white precipitate | Conforms |
IR Identification | Should comply with the reference spectrum | Comply with the reference spectrum |
Related Substances - Individual Impurity | ≤0.2% | 0.1% |
Related Substances - Total Impurities | ≤0.5% | 0.2% |
Residual solvent - Methanol | ≤0.3% | ND |
Residual solvent - Ethanol | ≤0.5% | ND |
Residual solvent - Ethyl Acetate | ≤0.5% | ND |
Residual solvent - Toluene | ≤0.089% | ND |
Loss on Drying | ≤0.5% | 0.40% |
Residual on Ignition | ≤1.0% | 0.05% |
Heavy metals | ≤10ppm | Conforms |
Assay | 98.0% - 102.0% | 101.0% |
Microbial Limit - Bacterial count | ≤1000cfu/g | <10cfu/g |
Microbial Limit - Mold and Yeast Count | ≤100cfu/g | <10cfu/g |
Microbial Limit - Escherichia Coli | Not detected | Not detected |
Conclusion | The sample conforms to the Specifications. |
Aniracetam – High-Purity Nootropic API Manufactured for Cognitive Health Innovations |
Aniracetam (CAS 72432‑10‑1) is a fat-soluble cognitive enhancer from the racetam family, widely recognized for its potential in supporting memory, attention, and neuroprotection. As a leading manufacturer and global supplier of Aniracetam powder, we offer GMP-compliant active pharmaceutical ingredients (APIs) engineered for advanced neurological applications, including Aniracetam supplements, research-grade nootropics, and cognitive disorder formulations.
Controlled Synthesis for Clinical-Grade Purity |
Our production of Aniracetam nootropic API is based on a robust chemical synthesis pathway starting from 2-pyrrolidone derivatives, conducted in strictly monitored reactor systems to ensure high yield and product consistency.
Raw Material Quality Control
Each batch begins with pharmaceutical-grade intermediates. In-process QC checks ensure structural integrity essential for Aniracetam AMPA receptor potentiator activity.
Precision Reaction and Crystallization
Our proprietary synthesis method supports optimal bioactivity, helping maximize Aniracetam for memory and attention disorders efficacy. Crystallization and solvent removal steps are conducted under vacuum to avoid degradation of the active molecule.
High-Purity Filtration & Drying
Final purification includes multiple solvent washes, followed by low-temperature vacuum drying. The result is a stable, fine Aniracetam powder ideal for capsule or tablet formulation.
Analytical Validation
Every lot undergoes HPLC, NMR, and MS testing to ensure compliance with global standards, including low residual solvents and heavy metals—supporting applications in Aniracetam for ADHD cognitive improvement and Aniracetam therapeutic potential in dementia and Alzheimer’s.
Scientific Backing & Application Potential |
Emerging research supports Aniracetam BDNF and amyloid‑β modulation, making it a candidate for age-related neurodegenerative diseases. Animal studies confirm Aniracetam anxiolytic effects in rodents, while new trials exploring Aniracetam safety and clinical evidence 2024 continue to build confidence in its nootropic and neuroprotective benefits.
We also support formulators targeting niche neurological markets. Whether your focus is Aniracetam for memory and attention disorders, AMPA modulation, or Aniracetam supplement innovation, our technical and regulatory teams provide comprehensive documentation and support.
